Some senior Biden administration officials were reportedly aware two weeks ago that there were problems with a Johnson & Johnson contractor – issues that could result in the delay of a substantial amount of doses of the vaccine, according to a report.
Workers at Emergent BioSolutions’ Baltimore plant mixed up the ingredients for Johnson & Johnson’s single-dose vaccine with ingredients from another shot, ruining 15 million doses, it was reported on Wednesday.
Future shipments of the vaccine have since been halted.
But two senior officials working on the COVID-19 response said problems at Emergent’s production plant became clear earlier this month, Politico reported.
And a third official told the outlet that the Department of Health and Human Services found out last week about Emergent’s blunder.
“It was no secret that Emergent did not have a deep bench of pharmaceutical manufacturing experts,” the official said.
The company’s failure will delay future shipments of the Johnson & Johnson vaccine, and distribution of